FA
VCEL icon

Friess Associates’s Vericel Corp VCEL Stock Holding History

Friess Associates’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-81,226
Closed -$1.42M – 143
2019
Q1 		$1.42M Buy
81,226
+655
+0.8% +$12K 0.1% 102
2018
Q4 		$1.4M Buy
+80,571
New +$1.21M 0.12% 96

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Friess Associates's VCEL Position: Q2 2019 in Review

Friess Associates sold out of Vericel Corp (VCEL) in Q2 2019, closing a stake of 81,226 shares — an estimated $1.42M sold.

Friess Associates first reported a position in VCEL in Q4 2018 and held it in 2 quarters. The position peaked at $1.42M in Q1 2019. 137 funds tracked by Wall St. Rank hold VCEL as of Q2 2019.

  • Friess Associates reported no remaining Vericel Corp position as of Q2 2019 after selling out during the quarter.
  • Friess Associates sold 81,226 Vericel Corp shares in Q2 2019, an estimated $1.42M.
  • Friess Associates first reported a position in Vericel Corp in Q4 2018 and held it in 2 quarters.
  • Friess Associates's Vericel Corp position peaked at $1.42M in Q1 2019.
  • 137 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2019.

Based on Friess Associates's 13F filing for Q2 2019, filed 14 Aug 2019.